PHARMACY COMPLIANCE RISK AREAS FOR 2014
|
|
- Oswald Glenn
- 6 years ago
- Views:
Transcription
1 PHARMACY COMPLIANCE RISK AREAS FOR San Juan Puerto Rico Regional Compliance Conference Darrell W. Contreras, Esq., LHRM, CHC-F, CHPC, CHRC 5 Risk Areas 1. Overbilling of Herceptin 2. Quality and Safety of hospital-compounded pharmaceuticals B Compliance with medication eligibility 4. Medicare Part D overbilling 5. False claims resulting from improper inducements 1
2 OIG Reviews Herceptin Overbilling of multi-use vials Reviewed 665 line items totaling approx. $1.75 million. 540 line items were incorrect (81%). Overpayment of $635,000 (36%). 440 mg Herceptin/vial Providers billed for the entire vial 1unit is 10mg Medicare Claims Process Manual Chapter 17 Drugs and Biologicals Rule 70: Where HCPCS is required, units are entered in multiples of the units shown in the HCPCS narrative description. For example, if the description for the code is 50 mg, and 200 mg are provided, units are shown as 4; When the dosage amount is greater than the amount indicated for the HCPCS code, the facility rounds up to determine units. When the dosage amount is less than the amount indicated for the HCPCS code, use 1 as the unit of measure. NOTE: Multi-use vials are not subject to payment for discarded amounts of drug or biological. (Section 40) 2
3 Example 1: HCPCS Drug Dosage J9355 Trastuzumab 10 mg Actual Dose: 140 mg Number of Units billed = Example 2: HCPCS Drug Dosage J3100 Tenecteplase 50 mg Actual Dose: 40 mg Number of Units billed = 3
4 Example 3: HCPCS Drug Dosage J9355 Trastuzumab 10 mg Actual Dose: 150 mg Vial Size: 440 mg Number of Units billed = 44 Correct Number of Units = OIG Herceptin Review Lessons Learned: Review your Herceptin billing What is the process to calculate units billed? Periodically review the reporting of billable units Check the math Understand different reporting methodologies Billing guidelines vary for different usage types 4
5 Compounding Pharmacies 2012 NECC Meningitis Outbreak Contaminated injections National attention Patients died Raised concern about documentation and quality of compounding State attention: Quality and documentation requirements added Federal attention: OIG Workplan OIG Workplan Oversight of pharmaceutical compounding (new) Quality of Care and Safety. We will describe Medicare s oversight of pharmaceutical compounding in Medicareparticipating acute care hospitals. We will also describe how State agencies and hospital accreditors assess such pharmacy services in hospitals. 5
6 State Boards of Pharmacy New Regulations Documentation of each compounding step. Audit trail for at least 2 years Pharmacist oversight Documented process What to Look For: Tracking adverse drug reactions to med prep Tracking quality measures within pharmacy 340B Compliance Audits HRSA oversees contract pharmacy arrangements in the 340B Program OIG Workplan: Tracking of drug sales Only eligible participants can receive 340B drugs. Duplicate discounts No payment of Medicaid rebates for 340B drugs Access to 340B ceiling prices Covered entity access to assess pricing (Required by ACA 7102) Drug manufacturer overcharges 6
7 340B Audits OPA requirements for 340B compliance (Feb 5, 2014): Conduct independent annual audits or implement an adequate mechanism for oversight of contract pharmacy arrangements; Maintain auditable records, compliant agreements with contract pharmacies and written policies and procedures related to contract pharmacy oversight; Ensure that 340B drugs are delivered only to eligible patients; "Carve out" Medicaid or develop an alternative arrangement with the state Medicaid agency to prevent duplicate discounts; and Maintain accurate information, including contract pharmacy information, in the HRSA 340B database. 340B Audits Lessons Learned: 1. Have a good 340B compliance program in place and audit recipient eligibility 2. Review the controls to prevent duplicate discounts 3. Check manufacturer pricing 7
8 Medicare Part D Billing fraud May 2012 OIG Report on Retail pharmacies 2637 participating pharmacies with questionable billing practices Issues: Billing for nonexistent prescriptions; Billing for brand name drugs when generic is dispensed; Billing for prescriptions that were not picked up. Medicare Part D Billing fraud Markers: Amounts billed per beneficiary Number of prescriptions per beneficiary Amounts billed per prescriber Number of prescriptions per prescriber Percentage of prescriptions for Schedule II drugs Percentage of prescriptions for Schedule III drugs Percentage of prescriptions for brand-name drugs Percentage of prescriptions that are refills, to identify pharmacies exhibiting aberrant billing patterns. 8
9 Medicare Part D Billing fraud Lesson Learned: 1. Periodic audit to match bills to prescriptions 2. Match billed medication to prescribed medication 3. Ensure pick-up is documented 4. Review the markers! Medicare False Billing Case Walgreens (April 20, 2012) $25 gift cards given to beneficiaries who transferred prescriptions to Walgreens from another pharmacy Excluded government health care programs Walgreens employees ignored exemptions and provided gift cards to all beneficiaries 9
10 Medicare False Billing Case False Billing? Impermissible inducement to federal health care program beneficiaries All claims that are submitted as a result of the inducement are false claims Result: $7.9 Million settlement Medicare False Billing Case Lesson Learned: Review all benefit programs to beneficiaries Ensure proper controls are in place Always ask, What if? 10
11 Questions? Darrell W. Contreras, Esq., LHRM, CHC-F, CHPC, CHRC Partner Phone: (863)
THE LATEST ON THE 340B FRONT
September 1, 2015 Connie Ouellette, Principal Carole Barker, Senior Consultant THE LATEST ON THE 340B FRONT berrydunn.com AGENDA Mega Guidance released! Audit update from HRSA Maintaining compliance Areas
More information11/12/2015 THE LATEST ON THE 340B FRONT AGENDA MEGA GUIDANCE RELEASED. Mega Guidance released. Audit update from HRSA. Maintaining compliance
November 19, 2015 Connie Ouellette, Principal Carole Barker, Senior Consultant THE LATEST ON THE 340B FRONT berrydunn.com AGENDA Mega Guidance released Audit update from HRSA Maintaining compliance Areas
More informationMarket Distortions from the 340B Drug Pricing Program
Market Distortions from the 340B Drug Pricing Program Adam J. Fein, Ph.D. www.drugchannels.net @DrugChannels The opinions and views expressed in this presentation are those of the author and may not reflect
More informationIn its written comments on our draft report, CMS concurred with our recommendation.
Page 2 Kerry Weems We recommend that Congress and CMS consider the results our review, including the data provided, in any deliberations regarding Medicare Part D reimbursement. In its written comments
More informationPhysician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010
Physician Injectable Drug List (PIDL) Department for Medicaid Services, HP, and Magellan Rx Management June 1, 2010 Physician-Administered Drugs Physician-administered drugs are drugs, other than vaccines,
More informationPhysician s Compliance Guide
Physician s Compliance Guide Updates to this guide will be posted on the Optum website and can be found at: http://www.optumcoding.com/product/updates/2013pcg/pcg13 Please use the following password to
More informationPBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.
Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationThe Value of Walgreens
The Value of Walgreens How Walgreens improves employer health plans through access, quality and lower costs Why millions of patients choose Walgreens And your options to move forward with Walgreens Walgreens
More informationTracking, Trending and Auditing Across a Multi-State Health System
Tracking, Trending and Auditing Across a Multi-State Health System Fifth National Medicare RAC Summit March 10, 2011 Susan Shiflett, RHIA, CHC Director Corporate Responsibility Catholic Health Initiatives
More informationQuestionable Billing and Geographic Hotspots Point to Potential Fraud and Abuse in Medicare Part D
HHS OIG Data Brief June 2015 OEI-02-15-00190 Questionable Billing and Geographic Hotspots Point to Potential Fraud and Abuse in Medicare Part D Key Takeaways: Since 2006, Medicare spending for commonly
More informationPHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS
PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS For Producer Audience Only - Please Do Not Distribute Regence has selected Prime Therapeutics as the Pharmacy benefits manager for its health plans.
More informationReport to the Social Services Appropriations Subcommittee
Report to the Social Services Appropriations Subcommittee Medicaid Coverage and Reimbursement for Outpatient Physical Therapy and Outpatient Occupational Therapy Prepared by the Division of Medicaid and
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More informationGeneral Providers. Tamper-Resistant Prescription Requirements
September 2008 Provider Bulletin Number 8138 General Providers Tamper-Resistant Prescription Requirements Effective with processing dates on and after October 1, 2008, written prescriptions for Kansas
More informationCurbing Prescription Drug Abuse in Medicaid
Curbing Prescription Drug Abuse in Medicaid Joint Legislative Health Care Oversight Committee October 12, 2010 Dr. Lisa Weeks, BSPharm, PharmD Pharmacy and Ancillary Services Division of Medical Assistance
More informationLegislative & Regulatory Update Brad Young, RxPlus Government Affairs
Legislative & Regulatory Update 2018 Brad Young, RxPlus Government Affairs Disclosures Brad Young reports no actual or potential conflicts of interest associated with this presentation. 2 Learning Objectives
More informationMedicaid Reimbursement for Tobacco Cessation Quitline Activities
Medicaid Reimbursement for Tobacco Cessation Quitline Activities Sharon Brown Financial Management Group (FMG) Center for Medicaid, CHIP and Survey & Certification (CMCS) 1 CMS issued a State Medicaid
More informationNew Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.
New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program 1 About Express Scripts Express Scripts is RHCA s chosen partner for administering your prescription plan We are a leading
More informationCARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:
RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription
More informationDIABETES TEST STRIPS REIMBURSEMENT REDUCTIONS TO INDEPENDENT PHARMACIES WILL NEGATIVELY IMPACT MEDICARE PATIENTS
DIABETES TEST STRIPS REIMBURSEMENT REDUCTIONS TO INDEPENDENT PHARMACIES WILL NEGATIVELY IMPACT MEDICARE PATIENTS NCPA Member Survey Results September 2012 CMS is considering cutting payments to pharmacies
More informationADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans
ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans DEPARTMENT: Medicare Compliance POLICY TITLE: RELATED DEPARTMENTS: All POLICY #: 706 C VERSION #: 4 REVISION DATE: Identifying
More informationJuly 30, VIA TO
July 30, 2012 VIA EMAIL TO DMEPOS@cms.hhs.gov Elliot Klein Centers for Medicare and Medicaid Services 7500 Security Boulevard Mail Stop C5-03-17 Baltimore, MD 21244-1850 RE: Inherent Reasonableness of
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on:
Statement Of The National Association of Chain Drug Stores For U.S. Senate Committee on Finance Hearing on: 10:00 a.m. National Association of Chain Drug Stores (NACDS) 1776 Wilson Blvd., Suite 200 Arlington,
More informationPHYSICIAN ENGAGEMENT IN THE COMPLIANCE PROCESS
PHYSICIAN ENGAGEMENT IN THE COMPLIANCE PROCESS R. Brett Short, CHC, CHPC, Chief Compliance Officer, UK HealthCare Sarah Couture, RN, CHC, Associate, Aegis Compliance and Ethics The Power of Advanced Medicine
More informationU.S. Department of Health and Human Services Office of Inspector General. An OIG Portfolio A
U.S. Department of Health and Human Services Office of Inspector General MEDICARE NEEDS BETTER CONTROLS TO PREVENT FRAUD, WASTE, AND ABUSE RELATED TO CHIROPRACTIC SERVICES February 2018 An OIG Portfolio
More informationOctober 27, Re: 340B Drug Pricing Omnibus Guidance (RIN 0906-AB08) Dear Captain Pedley:
October 27, 2015 Krista Pedley, Director Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane Mail Stop 08W05A Rockville, Maryland 20857 (submitted electronically)
More informationLegislative and Regulatory Update Michael Baxter APhA Director, Regulatory Affairs
Legislative and Regulatory Update 2018 Michael Baxter APhA Director, Regulatory Affairs 1 CPE Information and Disclosures Michael Baxter declares no conflicts of interest, real or apparent, and no financial
More informationCERT Oxygen Errors: The DME CERT Outreach and Education Task Force Responds
CERT Oxygen Errors: The DME CERT Outreach and Education Task Force Responds DME CERT Outreach and Education Task Force National Oxygen Webinar, July 22, 2014 1 Today s Presenters Michael Hanna, CERT Task
More informationWhat s New. Don t Forget! There are 2 different influenza vaccines available. Flu Vaccine. Michigan Newsletter Fall 2009
What s New Michigan Newsletter Fall 2009 Flu Vaccine Don t Forget! There are 2 different influenza vaccines available this year (one for seasonal flu and one for Novel H1N1 or swine flu). Both vaccines
More informationCBR201609: Diabetic Testing Supplies
Stay Tuned for Webinar Audio dial-in: 323 920 0091; PIN: 256-7691# For technical assistance, send email to support@anymeeting.com : Diabetic Testing Supplies 3:00 P.M. ET July 27, 2016 : Diabetic Testing
More informationSTATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION
STATE OF NEW JERSEY OFFICE OF THE STATE COMPTROLLER MEDICAID FRAUD DIVISION COMPLIANCE AUDIT REVIEW OF SUBOXONE FINAL AUDIT REPORT A. Matthew Boxer September 25, 2013 COMPTROLLER Executive Summary As part
More informationFlexRx 6-Tier. SM Pharmacy Benefit Guide
FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many
More informationMonitoring the Accuracy of Hospital Coding (OEI )
DATE: January 21, 1999 FROM: SUBJECT: TO: June Gibbs Brown Inspector General Monitoring the Accuracy of Hospital Coding (OEI-01-98-00420) Nancy-Ann Min DeParle Administrator Health Care Financing Administration
More informationRisk Classification Modeling to Combat Opioid Abuse
Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc. www.nciinc.com 11730 Plaza America
More informationCrowe Healthcare Webinar Series
Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President
More informationOverview. Provider Enrollment Requirements Member Eligibility Hearing Services Authorization and Billing Additional Information
Audiology Services Overview Provider Enrollment Requirements Member Eligibility Hearing Services Authorization and Billing Additional Information 2 Provider Enrollment 3 Alaska Medicaid Provider Enrollment
More informationMedicare Physical Therapy Billing Guidelines 2012
Medicare Physical Therapy Billing Guidelines 2012 Important Notice! A random sample of APTA members will soon be selected to respond to a survey about new physical therapy evaluation and reevaluation CPT.
More informationa guide to Reimbursement of Intermittent Catheters Know your options M2116N 04.08
a guide to Reimbursement of Intermittent Catheters 1 Know your options Coloplast Corp. Minneapolis, MN 55411 1.800.533.0464 usmedweb@coloplast.com www.us.coloplast.com is a registered trademark of Coloplast
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.
Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on the Budget Hearing on: 2:00 p.m. 210 Cannon House Office Building National Association of Chain
More informationTexas Vendor Drug Program Specialty Drug List Process. February 2019
Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed
More informationRound 2 DME Competitive Bidding Program
Round 2 DME Competitive Bidding Program Presented by Diane Caradeuc CMS-SMP Liaison This Senior Medicare Patrol educational effort is supported and funded by the Administration on Aging. DMEPOS Categories
More informationValue of Hospice Benefit to Medicaid Programs
One Pennsylvania Plaza, 38 th Floor New York, NY 10119 Tel 212-279-7166 Fax 212-629-5657 www.milliman.com Value of Hospice Benefit May 2, 2003 Milliman USA, Inc. New York, NY Kate Fitch, RN, MEd, MA Bruce
More informationNEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION
Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)
More informationBilling & Coding Guide
Billing & Coding Guide CMS established a unique J-code to facilitate reimbursement of ENVARSUS XR J7503 Suggested Coding and Medicare Allowables Coding Overview and Payment Rates Used to Report Code Description
More informationManaged Care Pushes for Safer Opioid Oversight
Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging
More informationIssues for Part D Compliance
HCCA- MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Issues for Part D Compliance Craig Miner, RPh, JD Division of Drug Plan Policy Babette S. Edgar, Pharm.D., MBA Division of Finance and Operations
More informationPrescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study
Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois
More informationALLERGY TESTING AND ALLERGY IMMUNOTHERAPY
ALLERGY TESTING AND ALLERGY IMMUNOTHERAPY Policy Neighborhood Health Plan reimburses contracted providers for the provision of medically necessary clinically indicated allergy testing and allergy immunotherapy
More informationDRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT
c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationDo not open the test booklet prior to being told to do so.
Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources
More information32 CFR (a)(4), (a)(6)(iii), and (a)(6)(iv)
CHAPTER 15 SECTION 1 ISSUE DATE: November 6, 2007 AUTHORITY: 32 CFR 199.14(a)(4), (a)(6)(iii), and (a)(6)(iv) I. APPLICABILITY This policy is mandatory for the reimbursement of services provided either
More informationNCPA LTC Division Newsletter
March 2016 NCPA LTC Division Newsletter NCPA Offers FDA Additional Information on Repackaging Draft Guidance NCPA recently joined with the American Society of Consultant Pharmacists (ASCP) in a follow
More informationRETIRED. Maximum Drug Dose Policy
RETIRED DRUG POLICY Policy Number 2017D0034A Maximum Drug Dose Policy Annual Approval Date 3/1/2017 Approved By UnitedHealthcare National Pharmacy & Therapeutics Committee United Healthcare Community Plan
More informationADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans
ADMINISTRATIVE POLICY AND PROCEDURES MedStar Family Choice Medicare Advantage Plans DEPARTMENT: Medicare Compliance POLICY TITLE: RELATED DEPARTMENTS: All POLICY #: 700C VERSION #: 3 REVISION DATE: Medicare
More informationOverview. Ontario Public Drug Programs, Ministry of Health and Long-Term Care
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2015 Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
More informationVA Walgreens Collaboration
VA Walgreens Collaboration Harry Leider, Chief Medical Officer Jim Wood, Vice President Federal December 15, 2015 Overview Walgreens Background VA / Walgreens Relationship VA Immunization Program IT Architecture
More information1. When are dispensers able to provide publicly funded naloxone emergency kits for Ontarians?
Ontario Public Drug Programs Division Ontario Naloxone Program for Pharmacies (ONPP) Frequently Asked Questions for Pharmacy Dispensers: Providing Publicly Funded Naloxone Kits and Claims Submission Using
More informationPart D PDE Data and the Opioid Epidemic
Part D PDE Data and the Opioid Epidemic State Data Resource Center Acumen, LLC August 30, 2017 3:30-4:30pm ET Outline Background Information on Opioid Use Helpful Part D Elements for Analysis How to Perform
More informationThis Frequently Asked Questions document contains various aspects of UIIP in the following sections. Overview Eligibility...
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2017: Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
More informationBOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director
BOARD OF PHARMACY- REGULATORY UPDATE Kimberly Grinston, J.D., Executive Director Disclosure and Conflict of Interest I declare no conflicts of interest, real or apparent, and no financial interest in any
More informationPharmaceutical Management Medicaid 2019
Pharmaceutical Management Medicaid 2019 Toll-free Contact Number: (888) 327-0671 Pharmacy Administration: (810) 244-1660 Introduction Pharmaceutical Management promotes the use of the most clinically appropriate,
More informationSTATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.
STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. Arizona Corporate Counsel Presentation May 8, 2018 Agenda 1. Overview of the Opioid
More informationPHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List
Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is
More informationVIA ELECTRONIC SUBMISSION: September 10, 2018
VIA ELECTRONIC SUBMISSION: http://www.regulations.gov Seema Verma Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1691-P 7500 Security Boulevard
More informationCERT PAP Errors: The DME CERT Outreach and Education Task Force Responds
CERT PAP Errors: The DME CERT Outreach and Education Task Force Responds DME CERT Outreach and Education Task Force National PAP Webinar, December 17, 2014 PAP CERT Errors Medical Records: Face-to-Face
More informationToday s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care
Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care 203 - Monday, April 16, 2018 Today s Presenters Ben Purser Former F.B.I. Special Agent Donna Thiel ProviderTrust Chief
More informationFRAUD PREVENTION IN MEDICAID. Dr. SERPIL TOKDEMIR YUCE, Ph.D. Office of Medicaid Inspector General Arkansas State USA
FRAUD PREVENTION IN MEDICAID Dr. SERPIL TOKDEMIR YUCE, Ph.D. Office of Medicaid Inspector General Arkansas State USA Mission of OMIG To detect and prevent fraud, waste, and abuse within the medical
More informationPharmacy Audit Recovery Guidelines
1/1E DAW 1 DAW 1 Error The prescription order does not indicate the prescriber ordered brand name. 2 /2E DAW 2 DAW 2 Not Documented The documentation does not specify the patient s request for brand. Pharmacy
More informationAgency Report Item 11: Oregon Health Authority Meningitis Vaccination Program in Lane County
Agency Report Item 11: Oregon Health Authority Meningitis Vaccination Program in Lane County Analyst: Linda Ames Request: Acknowledge receipt of a report on the meningitis vaccination program in Lane County.
More informationMedicare Part D Opioid Policies for 2019 Information for Patients
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Opioid Policies for 2019 Information for Patients Introduction Prescription opioid pain medications like oxycodone (OxyContin ), hydrocodone (Vicodin
More informationRe: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments
VIA Electronic Submission to http://www.regulations.gov September 29, 2009 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Docket
More informationMail Service Pharmacy
Mail Service s At A Glance Disclaimer: reserves the right to update its measures and measure sets to maintain measure relevancy and to remedy any unintended consequences that may arise during implementation.
More informationUNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI
Case 4:08-cv-01915-TCM Document 48 Filed 04/28/2009 Page 1 of 12 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EXPRESS SCRIPTS, INC., ) ) Plaintiff, ) ) vs. ) Cause No.: 4:08-cv-1915 ) WALGREEN
More informationFor the 2017/2018 Influenza Immunization Season. Patient Eligibility. Description. Ontario Public Drug Programs, Ministry of Health and Long-Term Care
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccines and Claims Submission using the Health
More information2009 Pain Coding Update and Pain Industry Business Trends
2009 Pain Coding Update and Pain Industry Business Trends Linda Van Horn, MBA June 13, 2009 2009 Pain Coding Update and Pain Industry Trends Agenda 2009 CPT Coding Updates Pay For Incentives ICD-10 American
More informationAmy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 CENTER FOR MEDICARE TO: FROM: SUBJECT: All Part D Sponsors Amy Larrick
More information- Description, Objectives, Operational Framework
2 1. CNCD - Overview (significance, causes, burden) 2. CDAP - Description, Objectives, Operational Framework 3. Research Findings of Study on CDAP - Research Objectives and Methodology - Limitations and
More informationFREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM
FREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM FLORIDA RX CARD Free statewide prescription assistance program Available to everyone in the state regardless of residency, immigration, or citizenship status
More informationPharmacy benefit guide
FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications
More informationWashington State Medicaid Prescription Drug Purchasing: Preferred Drug List
Washington tate Medicaid Prescription rug Purchasing: Preferred rug List NLPE Conference eptember 21, 2011 John Bowden Joint Legislative udit & eview Committee JLC Background he Joint Legislative udit
More informationOntario Public Drug Programs, Ministry of Health and Long-Term Care. For the Influenza Immunization Season
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccines and Claims Submission using the Health
More informationThe Oncology Drug Marketplace: Trends in Discounting and Site of Care
The Oncology Drug Marketplace: Trends in Discounting and Site of Care DECEMBER 2017 PREPARED BY: Aaron Vandervelde avandervelde@thinkbrg.com 202.480.2661 Eleanor Blalock eblalock@thinkbrg.com 202.480.2772
More informationPartial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report. User s Guide Sixth Edition. Prepared by
Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report User s Guide Sixth Edition Prepared by Partial Hospitalization Program Program for Evaluating Payment Patterns
More informationSub. S.B. 119 As Passed by the Senate
AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,
More informationMedicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
More informationStandards, Education, Verification. Patient Focused Certification
Standards, Education, Verification Patient Focused Certification PFC Training helps you achieve quality standards. Staff Certification is now available online www.pfctraining.org jahan@safeaccessnow.org
More informationAnalysis Item 13: Oregon Health Authority Meningitis Vaccination Program
Analysis Item 13: Oregon Health Authority Meningitis Vaccination Program Analyst: Linda Ames Request: Acknowledge receipt of a report on the meningitis vaccination program in Lane County. Recommendation:
More informationChapter 18 Section 15. Department Of Defense (DoD) Applied Behavior Analysis (ABA) Pilot For Non-Active Duty Family Members (NADFMs)
Demonstrations And Pilot Projects Chapter 18 Section 15 Department Of Defense (DoD) Applied Behavior Analysis (ABA) Pilot 1.0 PURPOSE Under authority of 10 United States Code (USC) 1092, TRICARE will continue
More informationMedicare STRIDE SM Physician Quality Program 2019 Program Overview
Medicare STRIDE SM Quality Program 2019 Program Overview Health Services- Managed by Network Medical Management 2019 Program 1 Medicare Advantage Quality Program Program Overview The Plan will support
More informationThe Age of Audits. The Age of Audits Optometry has never been targeted has that changed? What would you do??? The Age of Audits DISCLAIMER
Is this the Golden Age of audits? Joe W DeLoach, OD, FAAO CEO, Optometric Business Solutions Optometry has never been targeted has that changed? If you are filing claims, you are a target! DISCLAIMER I
More informationMedicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,
More informationSubstitute HB 523 Outline
Substitute HB 523 Outline 1. Creates Medical Marijuana Control Commission under the auspice of the Department of Commerce 9 member commission No more than 4 members of the Commission shall be from 1 political
More informationA Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)
A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) May 2014 RubiReview Program Overview... 3 Overview... 3 Adherence Packaging (RubiPaks)... 4 Eligibility... 4 Financial
More information2
1 2 3 4 5 6 7 8 9 ADAP client enrollment and client utilization reached their highest levels during FY2010. However, as a result of the national fiscal crisis and implementation of cost-containment measures,
More information340B Audit Experiences from 2015: What We Learned From Over 50 Audits
340B Audit Experiences from 2015: What We Learned From Over 50 Audits ROB NAHOOPII, PHARMD, MS, BCPS RICH BUCHER, JD, RPH TURNKEY PHARMACY SOLUTIONS Statement of Conflicts of Interest Rob Nahoopii Rich
More informationChapter 15 Section 1
Chapter 15 Section 1 Issue Date: November 6, 2007 Authority: 32 CFR 199.14(a)(3) and (a)(6)(ii) 1.0 APPLICABILITY This policy is mandatory for the reimbursement of services provided either by network or
More informationNEW PROVIDER ENROLLMENT FOR ADULT SITE
New Jersey Department of Health Vaccines for Children (NJVFC) Program P.O. Box 369 Trenton, NJ 08625-0369 Phone: (609) 826-4862 Fax: (609) 826-4868 INSTRUCTIONS: Email completed New Provider Enrollment
More information